Skip to main content
. Author manuscript; available in PMC: 2015 Jul 24.
Published in final edited form as: Oncogene. 2007 Aug 27;27(9):1273–1280. doi: 10.1038/sj.onc.1210746

Figure 6.

Figure 6

Intercepting PKCα-CARMA3 axis inhibits SK-OV3 in vitro invasion. SK-OV3 cells were infected with control Ad or Ad containing dominant-negative PKCα, CARMA3ΔCARD or Iκm, and then added into matrigel invasion chambers to analyse in vitro invasion as described in Supplementary Material. Lysophosphatidic acid (LPA, 10 µm) (a) or TNFα (50 ng ml−1) (b) was added in the underwells to stimulate cell invasion.